Page last updated: 2024-08-26

mizoribine and Connective Tissue Diseases

mizoribine has been researched along with Connective Tissue Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, S1
Kishimoto, M; Nomura, A; Ohara, Y; Ohde, S; Okada, M; Rokutanda, R; Shimizu, H; Suyama, Y; Yamaguchi, K1

Reviews

1 review(s) available for mizoribine and Connective Tissue Diseases

ArticleYear
[Renal involvement in connective tissue diseases].
    Nihon rinsho. Japanese journal of clinical medicine, 2009, Volume: 67, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Connective Tissue Diseases; Humans; Immunosuppressive Agents; Kidney Diseases; Methylprednisolone; Pulse Therapy, Drug; Ribonucleosides; Tacrolimus

2009

Other Studies

1 other study(ies) available for mizoribine and Connective Tissue Diseases

ArticleYear
Safety and efficacy of mizoribine in patients with connective tissue diseases other than rheumatoid arthritis.
    Rheumatology international, 2014, Volume: 34, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Aged; Connective Tissue Diseases; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Male; Middle Aged; Retrospective Studies; Ribonucleosides; Time Factors; Treatment Outcome

2014